Objective-11␤-Hydroxysteroid dehydrogenase type 1 (11␤-HSD1) catalyzes the intracellular reduction of inactive cortisone to active cortisol, the natural ligand activating the glucocorticoid receptor (GR). Peroxisome proliferatoractivated receptor-␥ (PPAR␥) is a nuclear receptor controlling inflammation, lipid metabolism, and the macrophage polarization state. In this study, we investigated the impact of macrophage polarization on the expression and activity of 11␤-HSD1 and the role of PPAR␥ therein. Methods and Results-11␤-HSD1 gene expression is higher in proinflammatory M1 and anti-inflammatory M2 macrophages than in resting macrophages, whereas its activity is highest in M2 macrophages. Interestingly, PPAR␥ activation induces 11␤-HSD1 enzyme activity in M2 macrophages but not in resting macrophages or M1 macrophages. Consequently, human M2 macrophages displayed enhanced responsiveness to the 11␤-HSD1 substrate cortisone, an effect amplified by PPAR␥ induction of 11␤-HSD1 activity, as illustrated by an increased expression of GR target genes. Conclusion-Our data identify a positive cross-talk between PPAR␥ and GR in human M2 macrophages via the induction of 11␤-HSD1 expression and activity. (Arterioscler Thromb Vasc Biol. 2012;32:677-685.)
M acrophages are heterogeneous cells. 1, 2 A proinflammatory cytokine-rich environment triggers an activation profile yielding classically activated macrophages (M1), which are involved in the Th1 immune response. In the presence of Th2 cytokines, such as interleukin (IL)-4 and IL-13, monocytes orient toward an alternative activation state (M2) and are involved in the Th2 immune response. 1 M1 macrophages mainly produce proinflammatory mediators, express major histocompatibility complex class II molecules, and have a high microbicidal activity, whereas M2 macrophages produce high amounts of anti-inflammatory molecules (IL-10, transforming growth factor-␤, and IL-1Ra), promote cell growth and tissue repair, and display a high endocytic capacity. 1 11␤-Hydroxysteroid dehydrogenase type 1 (11␤-HSD1) catalyzes the intracellular reduction of inactive cortisone and 11-dehydrocorticosterone to active cortisol and corticosterone, respectively, which are ligands of the glucocorticoid receptor (GR). 3 Glucocorticoid-activated GR regulates numerous metabolic and homeostatic processes, including carbohydrate, protein, and lipid metabolism, and exerts antiinflammatory and immunosuppressive properties. 4 11␤-HSD1 is expressed in several tissues, including liver, adipose tissue, and brain, 5, 6 and myeloid cells, such as dendritic cells and macrophages. 7 11␤-HSD1 is not expressed in human monocytes but is induced on differentiation into macrophages, and its expression is further enhanced by the antiinflammatory Th2 cytokines IL-4 and IL-13. 8 The inflammatory status of macrophages is controlled by nuclear receptors, such as the peroxisome proliferator-activated receptors (PPARs) ␣, ␤/␦, and ␥, 9 and the GR. Indeed, GR activation results in the polarization of monocytes to a specific subtype of M2 macrophages, termed M2c. 10 PPAR␥ is activated by natural (15-deoxy-⌬12, 14-prostaglandin J2) 11 and synthetic ligands, including the antidiabetic glitazones (rosiglitazone and pioglitazone) and the GW1929 com-pound. 12 In activated M1 macrophages, the anti-inflammatory PPAR␥-dependent transrepression pathway is initiated by sumoylation of the liganded-PPAR␥ ligand-binding domain maintaining the corepressor complex on nuclear factor-B response elements. 13 PPAR␥ also enhances the alternative activation and differentiation of monocytes into macrophages, 14, 15 thus leading to a more pronounced antiinflammatory M2 phenotype. 15 However, it is not known whether PPAR␥ and GR cross-talk in the control of macrophage polarization and functions.
Here, we show that 11␤-HSD1 enzyme activity is highest in M2 macrophages and that PPAR␥ ligands specifically induce 11␤-HSD1 enzyme activity in anti-inflammatory M2 but not in resting macrophages (RMs) and M1 macrophages. This novel mechanism may contribute to the antiinflammatory activities of PPAR␥ in M2 macrophages and could have consequences in inflammatory diseases, such as atherosclerosis.
Methods

Cell Culture
Human peripheral blood mononuclear cells were isolated from healthy donors by density gradient centrifugation. 16 Monocyte differentiation to RM occurred after 7 days of culture in RPMI 1640 medium (Invitrogen) supplemented with gentamicin (40 g/mL), L-glutamine (2 mmol/L) (Sigma-Aldrich), and 10% human serum (Abcys). M2 macrophages were obtained by differentiating freshly isolated monocytes with human IL-4 (15 ng/mL, Promocell) for 7 days. M1 macrophages were obtained by activating RMs with lipopolysaccharide (100 ng/mL) for 4 hours. Agonists for PPAR␥ (GW1929, rosiglitazone), PPAR␣ (GW7647), or PPAR␤/␦ (GW501516); the PPAR␥ antagonist (GW9662); RU486; cortisone; or dexamethasone was added as indicated.
Bone marrow-derived macrophages prepared from C57BL/6J mice 17 were treated with GW1929 (0.5, 1, 5 mol/L) or rosiglitazone (1, 5, 10 mol/L) for 24 hours.
RNA Extraction and Analysis
RNA was isolated from macrophages using Trizol (Invitrogen) and reverse transcribed, and cDNAs were quantified by quantitative polymerase chain reaction (Q-PCR) on a MX4000 apparatus (Agilent Biotechnologies) using the Brilliant II SYBR Green Q-PCR Master Mix (Agilent Biotechnologies) with specific primers (Table in the onlineonly Data Supplement). Tumor necrosis factor-␣ and IL-6 were measured using the Brilliant Multiplex Q-PCR Master Mix kit (Agilent Biotechnologies) with the following primers/probes: tumor necrosis factor-␣, 5Ј-CCCATGTTGTAGCAAACCCTCA-3Ј (forward), 5Ј-ATCTCTCAGCTCCAGGCCATTG-3Ј (reverse), and 5Ј-Cy5 TTGGCCCGGCGGTTCAGCCACT-3ЈDDQ2 (probe); IL-6, 5Ј-CAATAACCACCCCTGACCCAAC-3Ј (forward), 5Ј-AAGCTG-CGCAGAATGAGATGAG-3Ј (reverse), and 5Ј-FAM TGCCAG-CCTGCTGACGAAGCTGCA-3Ј-BHQ1 (probe); and cyclophilin, 5Ј-TGGTCAACCCCACCGTGTTC-3Ј (forward), 5Ј-TGCAAACAG-CTCAAAGGAGACG-3Ј (reverse), and 5ЈYakima Yellow TTGC-CGTCGACGGCGAGCCCTT-3Ј-EDQ (probe).
Electrophoretic Mobility Shift Assay
PPAR␥ and retinoid X receptor (RXR) ␣ were in vitro transcribed from the pSG5-hPPAR␥ and pSG5-hRXR␣ plasmids (Promega, Madison, WI). For the preparation of nuclear extracts, RM, M1, and M2 macrophages were collected in hypotonic buffer (15 mmol/L Hepes, pH 7.8, 10 mmol/L KCl, 2 mmol/L MgCl 2 , 0.1 mmol/L EDTA, 3 mmol/L dithiothreitol, and protease inhibitors). After 15 minutes of incubation at 4°C, nonidet P40, was added before centrifugation. The cell pellet was dissolved in hypertonic buffer (30 mmol/L Hepes, 50 mmol/L KCl, 300 mmol/L NaCl, 0.1 mmol/L EDTA, 3 mmol/L dithiothreitol, 10% glycerol); after 30 minutes of incubation at 4°C, nuclear extracts were collected. Proteins were incubated for 10 minutes in binding buffer (10 mmol/L Hepes, pH 7.8, 100 mmol/L NaCl, 0.1 mmol/L EDTA, 10% glycerol, 1 mg/mL bovine serum albumin) containing poly(dI-dC) (1 g) and herring sperm DNA (1 g). Double-stranded oligonucleotides containing the wild-type DR1-PPAR␥ response element (PPRE) present between nucleotides Ϫ2406 and Ϫ2393 of the human 11␤-HSD1 promoter, end-labeled using T4 polynucleotide kinase and ␥-32P ATP, was added as probe to the binding reaction. For supershift assays, monoclonal anti-human PPAR␥ antibody (Santa Cruz Biotechnology) was added to the binding reaction. DNA/protein complexes were resolved by nondenaturing polyacrylamide gel electrophoresis in 0.25 ϫ Tris-Borate-EDTA. Classical DR1-PPRE was used as positive control.
Plasmid Cloning and Transient Transfection Experiments
The reporter plasmid (11␤-HSD1-PPREwt) 6 -TK-pGL3 was generated by inserting 6 copies of the double-strand oligonucleotides (forward, 5Ј-CTTGAAGGGTTGAAAGGTCAAAACTAT-3Ј; reverse, 5Ј-ATAGTTTTGACCTTTCAACCCTTCAAG-3) into the pTK-pGL3 plasmid. Macrophages were transfected overnight in RPMI medium containing 10% human serum with reporter plasmids and expression vectors (pSG5-empty or pSG5-hPPAR␥) using jetPEI (Polyplus Transfection). Subsequently, cells were incubated for an additional 24 hours with GW1929 (600 nmol/L) or dimethyl sulfoxide, and luciferase and ␤-galactosidase activities were measured.
Chromatin Immunoprecipitation and Chromatin Immunoprecipitation-Sequencing Assays
Macrophages were cross-linked with 1% formaldehyde/PBS for 10 minutes 18 and collected in PBS, and nuclear extracts were prepared. The chromatin was fragmented to Ϸ500 bp in a 10 mmol/L Tris buffer pH 7.5 containing 1 mmol/L EDTA, 0.5 mmol/L EGTA, 100 mmol/L NaCl, 0.1% Na-deoxycholate, 0.5% N-lauroyl sarcosine, and 0.4% SDS using a Bioruptor sonication bath (Diagenode). Half of the chromatin was immunoprecipitated overnight in a 10 mmol/L Tris buffer, pH 7.5, containing 1 mmol/L EDTA, 0.5 mmol/L EGTA, 100 mmol/L NaCl, 0.1% Na-deoxycholate, 0.5% N-lauroyl sarcosine, and 0.08% SDS, and 1% Triton X-100 using either PPAR␥ antibodies or control IgG (Santa Cruz Biotechnology) in combination with Protein A/G Dynabeads (Invitrogen). Precipitates were washed with RIPA buffer. Eluates were obtained with 1% SDS in 50 mmol/L Tris pH8.0/1 mmol/L EDTA, and the crosslinking was reversed at 65°C overnight. Immunoprecipitated DNA was purified by phenol-chloroform-isoamilyc alcohol extraction and ethanol precipitation. Then, either a 150-bp region of the 11␤-HSD1 promoter area was amplified by polymerase chain reaction, using the primers 5Ј-GACACAAAGTGGATTAGATGTTTATT and 5Ј-ACATCCTGTAGCCTCTGGAA, or a 77-bp region of ␤-actin was amplified using 5Ј-AGTGTGGTCCTGCGACTTCTAAG and 5Ј-CCTGGGCTTGAGAGGTAGAGTGT.
Chromatin was used for immunoprecipitation using antibody against H3K9ac (Millipore). Chromatin immunoprecipitation (ChIP)sequencing was performed and analyzed as described, 19 including total tag number equalization before data visualization. H3K9ac ChIPsequencing data were visualized using the University of California, Santa Cruz, genome browser. H3K9ac ChIP-Q-PCR was performed on chromatin from several different donors using the following primers: 11␤-HSD1promoter 1, 5Ј-CAGGACCACTTCCAAGCATT-3Ј and 5Ј-CCAAAGAGAAGCCAGAGTGG-3Ј; 11␤-HSD1promoter 2, 5ЈCTTGGCCATCTGGAAGTCTC-3Ј and 5Ј-TGCTAGCCAATTT-CCCTGTC-3Ј; and negative control, 5Ј-CAGGATATACACCC-CCGTGA-3Ј and 5Ј-CAAAGTGCGTACACCTTGGTA-3Ј.
Short Interfering RNA Assays
Differentiated RMs were transfected with short interfering RNA (siRNA) specific for human PPAR␥ and nonsilencing control scram-bled siRNA (Ambion), using the transfection reagent DharmaFECT4 (Dharmacon). After 16 hours, cells were incubated with GW1929 (600 nmol/L) or vehicle (dimethyl sulfoxide) and harvested 24 hours later.
Adenovirus Generation
The recombinant adenovirus-green fluorescent protein and adenovirus-PPAR␥ were obtained as described. 20 Macrophages (1.5ϫ10 6 ) were infected at a multiplicity of 100 viral particles/cell by adding virus stocks directly to the culture medium. After 16 hours, cells were incubated for 24 hours in the absence or presence of GW1929 (600 nmol/L).
Protein Extraction and Western Blot Analysis
Cells were harvested in ice-cold lysis buffer (RIPA), proteins collected by centrifugation, separated by 10% SDS-PAGE, transferred to nitrocellulose membranes (Amersham), and revealed using goat polyclonal antibodies against 11␤-HSD1 (Abcam) or ␤-actin (Santa Cruz Biotechnology). After incubation with a secondary peroxidase-conjugated antibody (Santa Cruz Biotechnology), immunoreactive bands were revealed using ECL detection (Amersham), and band intensity was quantified by QuantityOne software.
11␤-HSD1 Enzyme Activity Assay
Cellular 11␤-HSD1 reductase activity was determined as described. 21 Cells were incubated for the indicated time periods (from 90 minutes to 8 hours) in serum-free medium containing cortisone (200 nmol/L) as substrate and [ 3 H]cortisone (10 nmol/L, 50 -60 Ci/mmol, ARC) as tracer. After incubation, medium was collected, and steroids were extracted with ethyl acetate. The extracts were dried under nitrogen, reconstituted with isopropanol containing a mixture of cortisol (F) and cortisone (E) (1.5 mg/mL each) and applied to silica gel thin layer chromatography plates. Cortisol and cortisone were separated in a chloroform/methanol solvent system (9:1, vol:vol), steroids were visualized under iodine and scraped off the plate, and radioactivity was counted. The conversion of cortisone to cortisol was calculated as the radioactivity index of (F/EϩF) and reflects 11␤-HSD1 enzyme activity. Each analysis was performed in triplicate.
Statistical Analysis
Statistically differences between groups were analyzed by ANOVA and Student t test and considered significant at PϽ0.05.
Results
11␤-HSD1 Reductase Expression and Activity Was Highest in M2 Macrophages
To determine whether 11␤-HSD1 expression and activity are dependent on the macrophage polarization states, 11␤-HSD1 expression was analyzed and compared between human RM, M1, and M2 macrophages. Expression of the M2 markers MR, AMAC1 ( Figure 1B and 1C) , IL-1Ra, IL-10, and transforming growth factor-␤ ( Figure I in the online-only Data Supplement), measured as positive control of alternative polarization, was elevated in M2 macrophages. 11␤-HSD1 mRNA levels were higher in M1 and, most pronouncedly, in M2 compared with RMs ( Figure 1A ). By contrast, in mouse bone marrow-derived macrophages, 11␤-HSD1 expression was not induced by IL-4 during differentiation, indicating that 11␤-HSD1 regulation is species specific and that it is not secondary to cellular differentiation (data not shown).
To investigate whether M1 and M2 macrophages also exhibit increased 11␤-HSD1 reductase activity compared with RMs, cells were incubated with radiolabeled cortisone as substrate, and conversion into cortisol was measured at different times. Surprisingly, the percentage of cortisone conversion to active cortisol was approximately 12% after 90 minutes and 37% after 8 hours of incubation of RMs with cortisone, whereas it was 10% after 90 minutes and 25% after 8 hours in M1 macrophages (Figure 2A and 2B) , indicating that the elevated 11␤-HSD1 mRNA in M1 macrophages does not translate in higher enzyme activity. By contrast, cortisone to cortisol conversion was already 50% after 90 minutes of cortisone incubation and reached 80% within 8 hours in M2 macrophages ( Figure 2C ). Thus, 11␤-HSD1 reductase activity is higher in M2 compared with RM and M1 macrophages. Moreover, expression of hexose-6-phosphate-deydrogenase, a cofactor for 11␤-HSD1, 22 was also higher in M2 compared with RMs (data not shown). This increased conversion of exogenous cortisone into active cortisol conferred a higher transactivation response to cortisone of a GR response ele- ment (GRE) driven-reporter vector in M2 compared with RMs, despite lower GR mRNA levels ( Figure II in the online-only Data Supplement). In addition, cortisone inhibited lipopolysaccharide-induced expression of IL-6, tumor necrosis factor-␣, and IL-1␤ in M2 but not RMs, indicating that cortisone to cortisol conversion results in antiinflammatory effects only in M2 macrophages ( Figure 2D-2F ). Dexamethasone, a GR-specific agonist that does not require metabolism by 11␤-HSD1 to be active, exerted anti-inflammatory properties both in RM and M2 macrophages ( Figure 2 ).
Cortisone Induces the Expression of GR Target Genes More Pronouncedly in M2 Macrophages
To determine the functional consequences of the higher 11␤-HSD1 activity in M2 macrophages, the expression of known GR target genes was measured in RM and M2 macrophages after cortisone activation for different time periods (Figure 3) . Cortisone induces the expression of glucocorticoid-induced leucine zipper ( Figure 3A) , angiopoietin-like 4 (ANGPTL4) 23 (Figure 3B ), and pyruvate dehydrogenase kinase 4 24 ( Figure 3C ) more strongly in M2 compared with RMs.
11␤-HSD1 Gene Expression Is Induced by PPAR␥ Activation in RM, M1, and M2 Macrophages
Because PPAR␥ plays a role in macrophage functions and polarization, we next investigated whether PPAR␥ regulates 11␤-HSD1 gene expression. Treatment with the PPAR␥ ligand GW1929 significantly increased 11␤-HSD1 gene and protein expression in RM, M1, and M2 macrophages ( Figure  4A and 4B ). This regulation occurred in a dose-dependent manner with rosiglitazone ( Figure IIIA The increase of 11␤-HSD1 gene expression by GW1929 was abolished in the presence of GW9662, a potent and selective PPAR␥ antagonist 25 (Figure 4C ). In line with this, 11␤-HSD1 induction on PPAR␥ activation was completely lost in PPAR␥ siRNA-transfected compared with scrambled siRNA-transfected macrophages ( Figure 4D ). Moreover, infection of macrophages with an adenovirus coding for PPAR␥ (adenovirus-PPAR␥) increased 11␤-HSD1 expression by approximately 3.5-fold compared with macrophages infected with an adenovirus coding for green fluorescent protein (adenovirus-green fluorescent protein), and the addition of GW1929 resulted in a further 2.5-fold induction of 11␤-HSD1 mRNA levels ( Figure 4E ).
PPAR␥ Regulates 11␤-HSD1 Gene Expression at the Transcriptional Level
To determine whether 11␤-HSD1 is a direct PPAR␥ target gene, the human 11␤-HSD1 promoter was analyzed in silico. A putative PPRE was identified between nucleotides 2406 and 2393. Electrophoretic mobility shift assays were performed to examine whether the PPAR␥-RXR heterodimer binds to this 11␤-HSD1-PPRE. Incubation of this labeled PPRE oligonucleotide with in vitro translated PPAR␥ and RXR␣ (indicated as RXR) resulted in the formation of a retarded complex ( Figure 5A , indicated by the arrow). Incubation with an anti-PPAR␥ antibody prevented complex formation, indicating binding-specificity of PPAR␥ to the PPRE site ( Figure 5A ). To test whether PPAR␥ activates transcription of the (Ϫ2406 to Ϫ2393)11␤-HSD1-PPRE, 6 copies of this element were cloned in front of the herpes simplex virus thymidine kinase promoter, yielding the (11␤-HSD1-PPRE) 6 -Tk-Luc reporter vector, which was transfected into differentiated primary human macrophages. Cotransfection of the pSG5-PPAR␥ expression vector led to a significant induction of (11␤-HSD1-PPRE) 6 transcriptional activity, an effect further enhanced by GW929 (600 nmol/L) ( Figure 5B ). The consensus DR1-PPRE site cloned in 6 copies, used as positive control, was also induced ( Figure 5C ).
Incubation of the 11␤-HSD1 labeled PPRE oligonucleotide with nuclear extracts from RM, M1, and M2 macrophages resulted in a weak retarded complex visible only in M2 macrophages. The presence of in vitro translated RXR␣ amplified the formation of the complex, which was again stronger with extracts from M2 macrophages and which was blocked by an anti-PPAR␥ antibody ( Figure 5D ). To evaluate whether PPAR␥ binds to the 11␤-HSD1 promoter in the cell, a ChIP assay was performed on RM and M2 macrophages. The genomic DNA region encompassing the PPRE of the 11␤-HSD1 gene was immunoprecipitated with an anti-PPAR␥ antibody. Q-PCR analysis revealed that PPAR␥ binding was stronger in M2 compared with RMs ( Figure 5E ). Because active promoters are marked with elevated levels of acetylation of histone H3 lysine 9 (H3K9ac) around their transcription start site, 26 we monitored the presence of H3K9ac at both known 11␤-HSD1 promoters 27 in RM and M2 macrophages. ChIP followed by high-throughput sequencing (ChIP-seq) indicated that H3K9ac was specifically present at the P2 promoter, which contains the identified PPRE, but not at the P1 promoter, in both RM and M2 macrophages ( Figure 5F ). Moreover, H3K9ac levels at promoter P2 were higher in M2 macrophages than in RM, as confirmed using ChIP-Q-PCR performed on chromatin from 2 different donors ( Figure 5F ). Finally, activity of the 11␤-HSD1-TK-Luc PPRE reporter vector was compared in RM and M2 macrophages in the absence or presence of GW1929 (600 nmol/L). Basal transcriptional activity was higher in M2 macrophages ( Figure 5G) , an effect further enhanced by GW1929. Overall, these data suggest that 11␤-HSD1 is expressed from the P2 promoter in human macrophages and that this promoter confers a stronger 11␤- HSD1 expression and response to PPAR␥ activation in M2 macrophages.
11␤-HSD1 Reductase Activity Is Induced by PPAR␥ Ligands in M2 Macrophages
To assess whether the induction of 11␤-HSD1 expression by PPAR␥ agonists results in an increased enzyme activity, differentiated RM, M1, and M2 macrophages were treated for 24 hours in the presence or absence of GW1929 and subsequently incubated with radiolabeled cortisone. Surprisingly, 11␤-HSD1 activity was not influenced by GW1929 in RM or M1 macrophages ( Figure 6A and 6B) , despite induction of 11␤-HSD1 mRNA expression ( Figure 4A ). However, GW1929-treated M2 macrophages displayed a 1.6-fold higher cortisone to cortisol conversion within 60 minutes, indicative of increased 11␤-HSD1 activity ( Figure 6C ). Thus, PPAR␥ activation induces 11␤-HSD1 enzyme activity specifically in M2 macrophages.
To determine the functionality of PPAR␥-induced 11␤-HSD1 enzyme activity in M2 macrophages, the expression of GR target genes was measured. Cortisone treatment more pronouncedly increased glucocorticoid-induced leucine zipper, pyruvate dehydrogenase kinase 4, and ANGPTL4 expression in M2 compared with RMs, an effect amplified by pretreatment with GW1929 ( Figure 6D-6F) and inhibited by the GR antagonist RU486 28 ( Figure IV in the online-only Data Supplement). These data further indicate that 11␤-HSD1 enzyme activity is higher and induced by PPAR␥ only in M2 macrophages.
Discussion
In this study, we report that expression of 11␤-HSD1, an enzyme that amplifies intracellular glucocorticoid action, is dependent on the macrophage phenotype. M2 macrophages express higher gene and protein levels of 11␤-HSD1 than RM and M1 macrophages. In line with the expression levels, Results are representative of 2 independent experiments. C, RMs were treated with vehicle or the PPAR␥ antagonist GW9662 (1 mol/L) in the absence or presence of GW1929 (600 nmol/L) for 24 hours. D, RMs were transfected with scrambled or human PPAR␥ short interfering RNA (siRNA) and subsequently treated with GW1929 (600 nmol/L) or dimethyl sulfoxide for 24 hours. E, RMs were infected with adenovirus (Ad)-green fluorescent protein (GFP) or Ad-PPAR␥ and subsequently stimulated for 24 hours with or without GW1929 (600 nmol/L). 11␤-HSD1 mRNA levels were measured by Q-PCR and normalized to those of cyclophilin. Results are expressed as the mean valueϮSD of triplicate determinations, representative of 3 independent experiments. Statistically significant differences are indicated (*PϽ0.05, **PϽ0.01, ***PϽ0.001).
11␤-HSD1 enzyme activity is higher in M2 than in RM and M1 macrophages, resulting in a more pronounced conversion of cortisone into active cortisol. Moreover, we demonstrate that PPAR␥ activation increases the expression and activity of 11␤-HSD1 in alternative human macrophages. In vitro experiments show that different PPAR␥ ligands, rosiglitazone and GW1929, increase the expression of 11␤-HSD1 mRNA in RM, M1 and M2 macrophages. The induction of 11␤-HSD1 expression by PPAR␥ appears to be species specific, because PPAR␥ inhibits its expression in mouse adipocytes. 29 Our data indicate that PPAR␥ ligands exert their effects via a PPAR␥-dependent mechanism. Indeed, both the PPAR␥ antagonist GW9662 and silencing of PPAR␥ expression abolished 11␤-HSD1 induction by GW1929. In addition, overex-pression of PPAR␥ in macrophages induced 11␤-HSD1 gene expression, an effect enhanced by GW1929. PPAR␥ activates 11␤-HSD1 transcription via a PPRE located in the 11␤-HSD1 P2 promoter. Binding of PPAR␥ to this site occurs also in the cell, as demonstrated by ChIP experiments, and is enhanced in M2 compared with RMs.
The regulation of 11␤-HSD1 enzyme activity by PPAR␥ activation is dependent on the macrophage phenotype. Surprisingly, PPAR␥ activation induced 11␤-HSD1 enzyme activity selectively in M2 macrophages, but not in RM nor M1 macrophages, although mRNA levels of 11␤-HSD1 were induced, albeit not to the same extent, by PPAR␥ ligands in all 3 cell types. Concomitantly, PPAR␥ induced cortisone conversion into cortisol in M2 macrophages, which was 6 (C) in the presence of pSG5-empty or pSG5-PPAR␥ vector, treated or not with GW1929 (600 nmol/L), and luciferase activity was measured. Statistically significant differences are indicated (*PϽ0.05, **PϽ0.01, ***PϽ0.001). D, EMSA was performed using in vitro produced RXR and PPAR␥ or nuclear extracts from RM, M1, and M2 in the absence or in the presence of exogenous hRXR␣, and supershift assays were performed using an anti-PPAR␥ antibody. E, Chromatin immunoprecipitation (ChIP) assays were performed and quantified using chromatin from RM and M2 macrophages, immunoprecipitated with rabbit IgG or PPAR␥-specific antibodies, and then subjected to polymerase chain reaction using primer pairs covering either the 11␤-HSD1 gene promoter or the ␤-actin gene. F, H3K9ac ChIP-sequencing data for RM and M2 macrophages. The y-axis shows the number of mapped tags sequenced on ChIP DNA from both RM and M2 macrophages. Promoters P1 and P2, as well as the identified PPREs, are indicated. ChIP experiments were performed on H3K9-immunoprecipitated chromatin from 2 independent donors using primers covering the 2 identified 11␤-HSD1 PPRE sites on the P1 and P2 promoters. Fold enrichments relative to a negative control region (set at 1) are shown. G, RM and M2 macrophages were transfected with the (DR1-11␤-HSD1 PPRE) 6 construct, treated or not with GW1929 (600 nmol/L). Statistically significant differences are indicated (*PϽ0.05, **PϽ0.01).
accompanied by an increased expression of the GR-target genes glucocorticoid-induced leucine zipper, pyruvate dehydrogenase kinase 4, and ANGPTL4.
We have previously demonstrated that PPAR␥ activation promotes M2 macrophage polarization. 15 On the basis of our results, 11␤-HSD1 activity appears to be a marker of macrophage M2 activation. More importantly, this high expression level of 11␤-HSD1 could contribute to the functions of M2 macrophages by converting cortisone to cortisol and thus activating GR target genes. Interestingly, it has been reported that ANGPTL4 binds to the extracellular matrix in ischemic tissues and reduces endothelial cell adhesion, prevents the organization of focal adhesion molecules and actin stress fibers, and decreases cell migration. 30 Therefore, M2 macrophage ANGPTL4 can exert paracrine effects on endothelial cells, thus participating in the modulation of angiogenesis in a hypoxic environment. M2 macrophages play also a role in tissue remodeling and repair and hence contribute to the resolution of inflammation. 1 Similarly, a role of 11␤-HSD1 in the resolution of inflammation has also been reported. 31 Using macrophages isolated from 11␤-HSD1-deficient mice, it has been shown that 11␤-HSD1-mediated intracellular active glucocorticoid formation enhances phagocytosis of neutrophils undergoing apoptosis during the resolution of inflammation. 31 Also, macrophages from 11␤-HSD1deficient mice overproduce proinflammatory cytokines and are hyperresponsive to lipopolysaccharide stimulation, suggesting that such macrophages exhibit an M1 phenotype. 32 Our data indicate that the activity 11␤-HSD1 is tightly related to the inflammatory status of human macrophages. Elevated 11␤-HSD1 activity in polarized M2 macrophages might contribute to their function in the anti-inflammatory response and the resolution of inflammation, with potential consequences on inflammatory diseases, such as atherosclerosis. M2 macrophage 11␤-HSD1 could thus contribute to the anti-inflammatory action of these cells within the atherosclerotic plaques. Finally, our findings demonstrate a novel cross-talk between the nuclear receptors PPAR␥ and GR. Figure 6 . Peroxisome proliferator-activated receptor-␥ (PPAR␥) activation increased 11␤-hydroxysteroid dehydrogenase type 1 (11␤-HSD1) activity in M2 macrophages, leading to the induction of glucocorticoid receptor (GR) target genes by cortisone. Resting macrophages (RM) (A), M1 macrophages (B), and M2 macrophages (C) were treated for 24 hours in the absence or in the presence of GW1929 (600 nmol/L) and subsequently incubated with radiolabeled cortisone (E) for the indicated time periods. Production of cortisol (F) was then measured. 11␤-HSD1 reductase activity was determined as the percentage conversion of cortisone to cortisol. Results are representative of 2 independent experiments. Statistically significant differences between control and treated cells are indicated (*PϽ0.05). RM and M2 macrophages were activated or not with GW1929 (600 nmol/L) for 24 hours and subsequently treated for another 24 hours with cortisone (1 mol/L). Pyruvate dehydrogenase kinase 4 (PDK4) (D), glucocorticoid-induced leucine zipper (GILZ) (E), and angiopoietin-like 4 (ANGPTL4) (F) mRNA levels were measured by quantitative polymerase chain reaction. Statistically significant differences between control and treated cells are indicated (*PϽ0.05, *PϽ0.01, ***PϽ0.001).
